Rockwell Medical
RMTI
#10619
Rank
ยฃ23.47 M
Marketcap
ยฃ5.82
Share price
0.13%
Change (1 day)
377.23%
Change (1 year)

P/E ratio for Rockwell Medical (RMTI)

P/E ratio as of September 2026 (TTM): -5.23

According to Rockwell Medical 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -5.23333. At the end of 2025 the company had a P/E ratio of -0.5557.

P/E ratio history for Rockwell Medical from 2001 to 2026

PE ratio at the end of each year

Year P/E ratio Change
2025-0.5557
2022-0.0594
2019-0.435719.53%
2018-0.3645-68.06%
2017-1.14-30.31%
2016-1.64-53.63%
2015-3.53
2013-0.6327

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Abbott Laboratories
ABT
28.3-640.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-11.1 112.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Mesa Laboratories
MLAB
103-2,075.30%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
83.4-1,692.83%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.